Literature DB >> 25122460

Effects of aging on osteogenic response and heterotopic ossification following burn injury in mice.

Jonathan R Peterson1, Oluwatobi N Eboda, R Cameron Brownley, Katherine E Cilwa, Lauren E Pratt, Sara De La Rosa, Shailesh Agarwal, Steven R Buchman, Paul S Cederna, Michael D Morris, Stewart C Wang, Benjamin Levi.   

Abstract

Heterotopic ossification (HO) is a common and debilitating complication of burns, traumatic brain injuries, and musculoskeletal trauma and surgery. Although the exact mechanism of ectopic bone formation is unknown, mesenchymal stem cells (MSCs) capable of osteogenic differentiation are known to play an essential role. Interestingly, the prevalence of HO in the elderly population is low despite the high overall occurrence of musculoskeletal injury and orthopedic procedures. We hypothesized that a lower osteogenicity of MSCs would be associated with blunted HO formation in old compared with young mice. In vitro osteogenic differentiation of adipose-derived MSCs from old (18-20 months) and young (6-8 weeks) C57/BL6 mice was assessed, with or without preceding burn injury. In vivo studies were then performed using an Achilles tenotomy with concurrent burn injury HO model. HO formation was quantified using μCT scans, Raman spectroscopy, and histology. MSCs from young mice had more in vitro bone formation, upregulation of bone formation pathways, and higher activation of Smad and nuclear factor kappa B (NF-κB) signaling following burn injury. This effect was absent or blunted in cells from old mice. In young mice, burn injury significantly increased HO formation, NF-κB activation, and osteoclast activity at the tenotomy site. This blunted, reactive osteogenic response in old mice follows trends seen clinically and may be related to differences in the ability to mount acute inflammatory responses. This unique characterization of HO and MSC osteogenic differentiation following inflammatory insult establishes differences between age populations and suggests potential pathways that could be targeted in the future with therapeutics.

Entities:  

Mesh:

Year:  2015        PMID: 25122460      PMCID: PMC4291203          DOI: 10.1089/scd.2014.0291

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  39 in total

Review 1.  Brief review of models of ectopic bone formation.

Authors:  Michelle A Scott; Benjamin Levi; Asal Askarinam; Alan Nguyen; Todd Rackohn; Kang Ting; Chia Soo; Aaron W James
Journal:  Stem Cells Dev       Date:  2012-01-04       Impact factor: 3.272

Review 2.  Heterotopic ossification following combat-related trauma.

Authors:  Benjamin K Potter; Jonathan A Forsberg; Thomas A Davis; Korboi N Evans; Jason S Hawksworth; Doug Tadaki; Trevor S Brown; Nicole J Crane; Travis C Burns; Frederick P O'Brien; Eric A Elster
Journal:  J Bone Joint Surg Am       Date:  2010-12       Impact factor: 5.284

3.  TGF-beta coordinately activates TAK1/MEK/AKT/NFkB and SMAD pathways to promote osteoclast survival.

Authors:  Anne Gingery; Elizabeth W Bradley; Larry Pederson; Ming Ruan; Nikki J Horwood; Merry Jo Oursler
Journal:  Exp Cell Res       Date:  2008-06-13       Impact factor: 3.905

4.  Dura mater stimulates human adipose-derived stromal cells to undergo bone formation in mouse calvarial defects.

Authors:  Benjamin Levi; Emily R Nelson; Shuli Li; Aaron W James; Jeong S Hyun; Daniel T Montoro; Min Lee; Jason P Glotzbach; George W Commons; Michael T Longaker
Journal:  Stem Cells       Date:  2011-08       Impact factor: 6.277

Review 5.  Heterotopic ossification: a review.

Authors:  Luc Vanden Bossche; Guy Vanderstraeten
Journal:  J Rehabil Med       Date:  2005-05       Impact factor: 2.912

6.  Alk2 regulates early chondrogenic fate in fibrodysplasia ossificans progressiva heterotopic endochondral ossification.

Authors:  Andria L Culbert; Salin A Chakkalakal; Edwin G Theosmy; Tracy A Brennan; Frederick S Kaplan; Eileen M Shore
Journal:  Stem Cells       Date:  2014-05       Impact factor: 6.277

7.  The effects of aging on the bone inductive activity of recombinant human bone morphogenetic protein-2.

Authors:  J C Fleet; K Cashman; K Cox; V Rosen
Journal:  Endocrinology       Date:  1996-11       Impact factor: 4.736

8.  Characterization of bone-marrow-derived rat mesenchymal stem cells depending on donor age.

Authors:  Kamila Gala; Anna Burdzińska; Marta Idziak; Jolanta Makula; Leszek Pączek
Journal:  Cell Biol Int       Date:  2011-10       Impact factor: 3.612

9.  Nonintegrating knockdown and customized scaffold design enhances human adipose-derived stem cells in skeletal repair.

Authors:  Benjamin Levi; Jeong S Hyun; Emily R Nelson; Shuli Li; Daniel T Montoro; Derrick C Wan; Fang Jun Jia; Jason C Glotzbach; Aaron W James; Min Lee; Mei Huang; Natalina Quarto; Geoffrey C Gurtner; Joseph C Wu; Michael T Longaker
Journal:  Stem Cells       Date:  2011-12       Impact factor: 6.277

10.  TNFalpha promotes osteogenic differentiation of human mesenchymal stem cells by triggering the NF-kappaB signaling pathway.

Authors:  Katrin Hess; Alexey Ushmorov; Jörg Fiedler; Rolf E Brenner; Thomas Wirth
Journal:  Bone       Date:  2009-05-03       Impact factor: 4.398

View more
  13 in total

1.  Direct Mouse Trauma/Burn Model of Heterotopic Ossification.

Authors:  Jonathan R Peterson; Shailesh Agarwal; R Cameron Brownley; Shawn J Loder; Kavitha Ranganathan; Paul S Cederna; Yuji Mishina; Stewart C Wang; Benjamin Levi
Journal:  J Vis Exp       Date:  2015-08-06       Impact factor: 1.355

Review 2.  Heterotopic Ossification Following Upper Extremity Injury.

Authors:  Shailesh Agarwal; Shawn Loder; Benjamin Levi
Journal:  Hand Clin       Date:  2017-05       Impact factor: 1.907

Review 3.  Mechanisms of bone development and repair.

Authors:  Ankit Salhotra; Harsh N Shah; Benjamin Levi; Michael T Longaker
Journal:  Nat Rev Mol Cell Biol       Date:  2020-09-08       Impact factor: 94.444

Review 4.  Microenvironmental factors that regulate mesenchymal stem cells: lessons learned from the study of heterotopic ossification.

Authors:  Chen Kan; Lijun Chen; Yangyang Hu; Haimei Lu; Yuyun Li; John A Kessler; Lixin Kan
Journal:  Histol Histopathol       Date:  2017-03-22       Impact factor: 2.303

5.  Combined reflectance and Raman spectroscopy to assess degree of in vivo angiogenesis after tissue injury.

Authors:  Shailesh Agarwal; William R Lloyd; Shawn J Loder; Michael T Chung; Charles Hwang; Michael D Morris; Benjamin Levi
Journal:  J Surg Res       Date:  2016-09-19       Impact factor: 2.192

6.  Disruption of the mouse Bmal1 locus promotes heterotopic ossification with aging via TGF-beta/BMP signaling.

Authors:  Qian Liang; Yingsi Lu; Lu Yu; Qingqing Zhu; Wenlin Xie; Yun Wang; Liping Ye; Qiji Li; Shaoyu Liu; Yan Liu; Chengming Zhu
Journal:  J Bone Miner Metab       Date:  2021-10-09       Impact factor: 2.626

7.  Endogenous CCN family member WISP1 inhibits trauma-induced heterotopic ossification.

Authors:  Ginny Ching-Yun Hsu; Simone Marini; Stefano Negri; Yiyun Wang; Jiajia Xu; Chase Pagani; Charles Hwang; David Stepien; Carolyn A Meyers; Sarah Miller; Edward McCarthy; Karen M Lyons; Benjamin Levi; Aaron W James
Journal:  JCI Insight       Date:  2020-07-09

8.  The Systemic Effect of Burn Injury and Trauma on Muscle and Bone Mass and Composition.

Authors:  Jacob Rinkinen; Charles D Hwang; Shailesh Agarwal; Eboda Oluwatobi; Jonathan Peterson; Shawn Loder; Robert C Brownly; Timothy Cummings; Paul S Cederna; Benjamin Levi
Journal:  Plast Reconstr Surg       Date:  2015-11       Impact factor: 4.730

9.  Inhibition of connexin 43 prevents trauma-induced heterotopic ossification.

Authors:  Bing Tu; Shen Liu; Guangwang Liu; Zhiwei Li; Yangbai Sun; Cunyi Fan
Journal:  Sci Rep       Date:  2016-11-16       Impact factor: 4.379

Review 10.  Diagnosis of Klippel-Trenaunay syndrome and extensive heterotopic ossification in a patient with a femoral fracture: a case report and literature review.

Authors:  Wanbo Zhu; Kai Xie; Jiazhao Yang; Li Li; Xujin Wang; Lei Xu; Shiyuan Fang
Journal:  BMC Musculoskelet Disord       Date:  2020-04-11       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.